Organic Active Ingredients TRIZ Cases

Isotopic substitution of hydrogen with deuterium in psilocybin extends metabolic stability while enabling legal detection via unique signatures.

Nanostructured cellulose prevents agglomeration of nanosized pharmaceutical particles, improving dissolution rate and bioavailability.

Organozinc coupling synthesizes SGLT2 inhibitors to control blood glucose without side effects from conventional agents.

Combining ipatasertib, atezolizumab, and taxane targets metastatic triple-negative breast cancer through synergistic pathway inhibition.

Thiocarbamate inhibitors combined with lipid carriers resolve low aqueous solubility, enabling effective oral dosing for cancer treatment.

Applying eugenol emulgel softens cured resin, lowering debonding force and preventing enamel damage during orthodontic treatment.

Targeting CD105-expressing fibroblasts with antagonists reduces tumor vascularity and overcomes resistance in castration-resistant prostate cancer.

Novel fused bicyclic heteroaromatic compounds act as potent RAF kinase inhibitors.

Multiblock poly(sarcosine) copolymers self-assemble into micelles to encapsulate hydrophobic drugs in aqueous solutions.

Adjusting rilpivirine dosage to 25 mg daily suppresses HIV viral load in children while minimizing adverse drug reactions.

Formula I compounds inhibit GSK-3 to reduce neuronal toxicity and neuroinflammation in Alzheimer's disease.

A pharmaceutical composition combining forskolin and retinoic acid protects auditory cells from cisplatin-induced damage.

Formula I urea compounds inhibit the SGLT1 transporter, reducing intestinal glucose absorption and lowering blood sugar levels in diabetic models.

Non-nutritive sugars form water-soluble complexes with poorly soluble erectile dysfunction drugs, resolving delayed onset and inconsistent bioavailability.

Intranasal salvinorin A delivery bypasses hepatic metabolism to improve bioavailability while avoiding manic side effects from 5HT2A receptor activity.

Pre-mixed ascorbic acid formulations eliminate dilution steps by using stabilizing agents to maintain room temperature stability.

Compounds inhibit triple mutant EGFR variants, overcoming resistance to osimertinib while reducing on-target toxicities.

VMAT2 inhibitors modulate monoamine transport to reduce symptom severity while minimizing off-target side effects in mood disorders.

Antibody-IR700 conjugates target cancer cells to induce selective necrosis via near-infrared light, reducing harm to normal tissues.

Cyclosporin acts as an intermediary to prevent nasolacrimal stenosis and keratoconjunctivitis during chemotherapy.

Liposomal formulations deliver chemotherapeutic agents directly into the peritoneal cavity to enhance drug penetration and patient tolerability.

Indazole derivatives inhibit fungal cytochrome b and Hsp90 to overcome fluconazole resistance in Candida albicans.

Segmenting the core structure from sugar modules resolves the contradiction between low water solubility and high antitumor activity in curcumin derivatives.

Compound Ia inhibits BRAF dimers to overcome resistance and relapse in brain metastatic melanoma patients.

5-Alkynyl-pyridine compounds inhibit PI3Kalpha activity, resolving the lack of effective pathway inhibitors in cancer treatment.

Silver nitrate substitution reaction converts cyanocobalamin to hydroxocobalamin hydrochloride in a water-methanol solvent system.

Combining sarilumab with DMARDs targets the IL-6R pathway to inhibit structural damage progression in rheumatoid arthritis patients.

Dietary fibres modulate neuroendocrine responses to alleviate gastrointestinal discomfort in medical nutrition products.

A continuous Z-value metric classifies pediatric septic shock patients using gene expression mosaics.

Pyrazole and imidazole derivatives selectively inhibit orexin receptors, addressing the inability of current treatments to target CNS dysfunctions.

Selective compounds detect TDP43 aggregates across the blood-brain barrier, resolving the bottleneck of insensitive diagnosis in ALS and FTD.

A thermosensitive liposome formulation uses a bilayer containing at least 15% DPPG2 to control drug release.

Targeting the MAPK signaling pathway with RAF, ERK1/2, and MEK1/2 inhibitors prevents hearing threshold shifts caused by cisplatin chemotherapy.

Antibody drug conjugate targets IL-13Rα2-expressing cancer cells using a pyrrolobenzodiazepine warhead to reduce recurrence in glioblastoma.

E3 ligase-binding moieties bridge BTK to ubiquitin complexes, enabling proteasomal degradation that bypasses C481S mutation resistance.

Polyvinyl alcohol hydrogel compositions retain moisture to sustain chlorhexidine release at oral tissues.

15dPGJ2-EA induces endoplasmic reticulum stress in virus-infected cells, reducing wart size while sparing healthy tissue from non-selective toxicity.

PTC299 targets both viral replication and immune response to reduce cytokine storms in COVID-19 treatment.

Replacing mannitol with lactose or trehalose prevents vial breaking and water release, ensuring copanlisib stability at pH levels above 5.5.

A bivalent metal salen complex traps free radicals through coordination bonding to maintain product stability.

Replacing mouse-derived SINE elements with human IRES sequences in a trans-acting molecule eliminates retrotransposition risks while boosting protein synthesis.

Liposome encapsulation delivers Toll-like receptor inhibitor prodrugs directly to tumor sites.

Hot-melt granulation disperses agomelatine within cross-linked polyvinylpolypyrrolidone pores to create a stable amorphous solid dispersion.

Developing a synthesis process for an IDO inhibitor with modified chemical structures to enhance tryptophan levels and anti-tumor responses.

Novel heterocyclic compounds inhibit PAS kinase activity to modulate glycogen synthesis and cellular metabolism.

Formula I compounds act as opioid receptor modulators to lower ghrelin levels, mitigating weight gain from atypical antipsychotics.

Radial cylinder chambers and axial pump cover segments recirculate drain oil through connection grooves, reducing overall transmission size.

Fused pyrimidine compounds inhibit mutant EGFR and HER2 kinases, overcoming low potency of current kinase inhibitors in lung cancer treatment.

Hydrophobically-modified polymer foam expands in body cavities to form a stable hemostatic barrier upon contact with blood.

Anti-Sortilin antibodies resolve the lack of effective Sortilin modulation by blocking ligand interactions, thereby treating neurodegenerative diseases.

Disposable capsules eliminate mesh maintenance and user measurement errors while ensuring sterile, accurate aerosol delivery.

Replacing hexane with cyclohexane eliminates neurotoxicity and boosts cannabinoid purity above 95%.

NDGA metabolites block EGFR and IGF-1R to treat resistant proliferative disorders.

Biaryl derivatives replace carboxylic acid substitutions with ether linkages to overcome insufficient therapeutic efficacy in diabetes treatment.

Combining PI3Kbeta inhibition with immune checkpoint blockade targets PTEN-deficient epithelial cancers.

Segmented nucleoside backbones with specific ring substituents improve oral bioavailability while maintaining high inhibition efficacy against PRMT5.

Administering PCDH1-binding agents prevents viral entry, reducing mortality from hantavirus pulmonary syndrome.

nSMase2 inhibitors block the viral budding stage, addressing the bottleneck where current antiretroviral therapies fail to target this critical lifecycle step.

A double-layer tablet combines fast-release and sustained-release layers to deliver Mosapride with controlled kinetics.

Thiophene derivatives block the IgE-FcεRI interaction, offering therapeutic options beyond conventional antihistamines.

Combining acrylate copolymers with specific coalescents resolves the trade-off between adhesion strength and optical brightness in nail varnishes.

A solid oral extended release dosage form uses polyethylene oxide and anionic surfactants to deliver active agents via a controlled matrix.

Palladium catalyzed synthesis of phosphonate esters simplifies equipment requirements and boosts yield for himbacine analog production.

Inhibiting Semaphorin 4D reduces MDSC induction, countering tumor-mediated immunosuppression and improving cancer treatment efficacy.

Pyrazole derivatives block monocyte macrophage recognition of opsonized platelets, avoiding corticosteroid toxicities.

A silicone acrylate hybrid compatibilizing agent integrates adhesive chemistries to maintain a single phase formulation.

CRX 547 lipid mimetic induces TRIF biased immune response while minimizing MyD88 dependent inflammatory cytokines.

Ozonolysis of beta-pinene replaces expensive valencene, reducing solvent waste and purification steps while achieving high yields.

Combining an elastase inhibitor with glucocorticoids protects muscle progenitor cells and stabilizes muscle fibers during treatment.

Radiolabeled MCR1 ligand conjugates overcome vemurafenib resistance by delivering precise radiation to metastatic melanoma cells.

Substituted bridged urea analogs optimize sirtuin modulation to overcome limited specificity and efficacy in existing therapies.

Stabilized cyanogenic compounds activate white blood cell counts to eliminate pathogens without triggering antibiotic resistance.

Liposomal mitomycin C prodrugs reduce systemic toxicity while achieving synergistic antineoplastic effects with radiation therapy.

Arginine mediates fentanyl penetration across the buccal mucosal barrier, resolving slow onset of action in water-free dissolution.

Novel imidazole derivatives inhibit parasite growth by targeting the Falcilysin enzyme.

Naphthodiazepinedione derivatives act as P2X4 receptor antagonists to treat multiple sclerosis.

Chimeric antigen receptor targeting human leukocyte antigen G directs immune cells to kill solid tumor cells, overcoming low homing efficiency.

Amino-substituted pyrimidopyrrole compounds inhibit IRAK4 kinase activity for treating autoimmune and inflammatory diseases.

Folate-conjugated epoxyeicosatrienoic acid analogs bind renal folate receptors to reduce cisplatin-induced nephrotoxicity through targeted delivery.

Novel 6-amino-7-bicyclo-7-deaza-purine compounds inhibit protein kinases to treat dysregulated enzyme activity.

Novel RET kinase inhibitors utilize diverse aryl and heteroaryl substituents to block abnormal enzyme activity in mutated cancer variants.

Pentacyclic pyridoindolobenzazepine derivatives optimize physicochemical properties through specific molecular topology and substituent placement.

Oral N-tert-butyl-3-pyrimidine sulfonamide capsules reduce spleen size and bone marrow fibrosis by targeting the JAK2V617F driver, avoiding transplant risks.

A chiral column resolves sulfoxide enantiomers while light irradiation racemizes the unwanted isomer for reuse.

Formula I cycloalkyl derivatives inhibit ASK-1 signaling pathways to manage hepatic steatosis and non-alcoholic fatty liver disease progression.

A mushroom extraction method combining subcritical fluid processing with cellulase enzyme treatment to release intracellular active ingredients.

Triazolyl pyrimidinone compounds inhibit phosphodiesterase 2 to treat central nervous system disorders.

Merging skimmed milk powder with sphingomyelin-enriched whey protein concentrate overcomes the trade-off between bioactive quantity and manufacturing ease.

Recombinant microbial cells convert simple carbon sources into siderophore monomers, resolving low productivity and high manufacturing costs.

Trifluoroethyl-substituted 3-hydroxypyridin-4-one derivatives cross the blood-brain barrier to sequester toxic iron.

Antisense oligonucleotides modulate OPA1 mRNA to increase functional protein levels in the eye.

Replacing PVC with polyethylene or glass in a parenteral kit prevents lipophilic solvent extraction of toxic phthalates, protecting patients and staff.

Inhibiting D-amino acid oxidase with esomeprazole elevates D-serine levels, addressing schizophrenia negative symptoms without excitotoxicity.

An antioxidant compound protects N-acetylcysteine from oxidation to maintain stability and therapeutic effectiveness against skin outbreaks.